(GMCR, STEM, DSCO) CRWENewswire Stocks In Action
- 2012/02/03 06:43:33 投稿
- 再生数：21
- マイリスト数：0
StemCells Incorporated - symbol STEM - reported that the FDA has authorized the initiation of a Phase I/II clinical trial of the Company's proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degenerationOn its first quarter fiscal 2012, Green Mountain Coffee Roasters Incorporated - symbol GMCR - posted GAAP operating income of $145.8 million, compared to $23.3 million in the same period the prior year